Zypadhera(TM) Receives Positive Opinion from the European Committee for Medicinal Products for Human Use (CHMP) for Maintenance Treatment of Schizophrenia INDIANAPOLIS, Sep. 26, 2008 (Canada NewsWire ...
Eli Lilly and Company (LLY) has announced that the European Commission has approved the use of Zypadhera (olanzapine powder and solvent for prolonged release suspension for injection, also known as ...
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Zypadhera (olanzapine powder and solvent for prolonged release suspension for injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results